Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion

British Journal of Cancer

Volumn 99, Issue 7, 2008, Pages 1114-1120

  Lambert, L A ^a   Whyteside, A R ^a   Turner, A J ^a   Usmani, B A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cell invasion; Endothelin converting enzyme 1 (ECE 1); Neprilysin; Prostate cancer; Suppressor

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 1A; ENDOTHELIN CONVERTING ENZYME 1B; ENDOTHELIN CONVERTING ENZYME 1C; ENDOTHELIN CONVERTING ENZYME 1D; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL INVASION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; STROMA CELL;

ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; HUMANS; ISOENZYMES; MALE; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING;

EID: 53049107711     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604631     Document Type: Article

References (31)

1. Ahmed SI, Thompson J, Coulson JM, Woll PJ (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 22: 422-431
2. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147
3. Arun B, Kilic G, Ashfaq R, Saboorian HM, Gokaslan T (2001) Endothelin converting enzyme-1 expression in endometrial adenocarcinomas. Cancer Invest 19: 779-782
4. Awano S, Dawson LA, Hunter AR, Turner AJ, Usmani BA (2005) Endothelin system in oral squamous carcinoma cells: Specific siRNA targeting of ECE-1 blocks cell proliferation. Int J Cancer 118(7): 1645-1652
5. Berger Y, Dehmlow H, Blum-Kaelin D, Kitas EA, Loffler BM, Aebi JD, Juillerat-Jeanneret L (2005) Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. J Med Chem 48: 483-498
6. Brown CD, Barnes K, Turner AJ (1998) Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Lett 424: 183-187
7. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT, Nanus DM (2001) Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res 7: 1370-1377
8. Dawson LA, Maitland NJ, Berry P, Turner AJ, Usmani BA (2006) Expression and localization of endothelin-converting enzyme-1 in human prostate cancer. Exp Biol Med (Maywood) 231: 1106-1110
9. Dawson LA, Maitland NJ, Turner AJ, Usmani BA (2004) Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. Br J Cancer 90: 1577-1582
10. Eberl LP, Egidy G, Pinet F, Juillerat-Jeanneret L (2000) Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J Cardiovasc Pharmacol 36: S354-S356
11. Egidy G, Eberl LP, Valdenaire O, Irmler M, Majdi R, Diserens AC, Fontana A, Janzer RC, Pinet F, Juillerat-Jeanneret L (2000a) The endothelin system in human glioblastoma. Lab Invest 80: 1681-1689
12. Egidy G, Juillerat-Jeanneret L, Jeannin JF, Korth P, Bosman FT, Pinet F (2000b) Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Pathol 157: 1863-1874
13. Godara G, Pecher S, Jukic DM, D'Antonio JM, Akhavan A, Nelson JB, Pflug BR (2007) Distinct patterns of endothelin axis expression in primary prostate cancer. Urology 70: 209-215
14. Kuruppu S, Reeve S, Ian Smith A (2007) Characterisation of endothelin converting enzyme-1 shedding from endothelial cells. FEBS lett 581(23): 4501-4506
15. Lang SH, Stower M, Maitland NJ (2000) In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Br J Cancer 82: 990-997
16. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
17. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P, Tougard C (2003) Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 278: 545-555
18. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW (1995) Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1: 944-949
19. Orzechowski HD, Gunther A, Menzel S, Zimmermann A, Funke-Kaiser H, Real R, Subkowski T, Zollmann FS, Paul M (2001) Transcriptional mechanism of protein kinase C-induced isoform-specific expression of the gene for endothelin-converting enzyme-1 in human endothelial cells. Mol Pharmacol 60: 1332-1342
20. Orzechowski HD, Richter CM, Funke-Kaiser H, Kroger B, Schmidt M, Menzel S, Bohnemeier H, Paul M (1997) Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. J Mol Med 75: 512-521
21. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM (1998) Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4: 50-57
22. Roosterman D, Cottrell GS, Padilla BE, Muller L, Eckman CB, Bunnett NW, Steinhoff M (2007) Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling. Proc Natl Acad Sci USA 104: 11838-11843
23. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Loffler BM (1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328(Pt 3): 871-877
24. Shimada K, Takahashi M, Ikeda M, Tanzawa K (1995) Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371: 140-144
25. Shimada K, Takahashi M, Tanzawa K (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275-18278
26. Smollich M, Gotte M, Yip GW, Yong ES, Kersting C, Fischgrabe J, Radke I, Kiesel L, Wulfing P (2007) On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer. Breast Cancer Res Treat 106: 361-369
27. Sumitomo M, Iwase A, Zheng R, Navarro D, Kaminetzky D, Shen R, Georgescu MM, Nanus DM (2004) Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5: 67-78
28. Usmani BA, Harden B, Maitland NJ, Turner AJ (2002) Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin Sci (Lond) 103(Suppl 48): 314S-317S
29. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB (1999) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264: 341-349
30. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895
31. Zhan L, Xiang B, Muthuswamy SK (2006) Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors. Cancer Res 66: 5201-5208